Wednesday, June 15, 2016

BRIEF-Emergent Biosolutions Inc receives FDA orphan drug status for BioThrax

* Emergent BioSolutions Inc receives FDA orphan drug status

for BioThrax for post-exposure prophylaxis of anthrax disease

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)